Repine Thomas B, Perkins Jeremy G, Kauvar David S, Blackborne Lorne
William Beaumont Army Medical Center, El Paso, TX, USA.
J Trauma. 2006 Jun;60(6 Suppl):S59-69. doi: 10.1097/01.ta.0000219013.64168.b2.
Most indications for whole blood transfusion are now well managed exclusively with blood component therapy, yet the use of fresh whole blood for resuscitating combat casualties has persisted in the U.S. military.
Published descriptions of whole blood use in military and civilian settings were compared with use of whole blood at the 31st Combat Support Hospital (31st CSH) stationed in Baghdad in 2004-2005.
Concerns about logistics, safety, and relative efficacy of whole blood versus component therapy have argued against the use of whole blood in most settings. However, military physicians have observed some distinct advantages in fresh warm whole blood over component therapy during the massive resuscitation of acidotic, hypothermic, and coagulopathic trauma patients. In this critical role, fresh whole blood was eventually incorporated as an adjunct into a novel whole-blood-based massive transfusion protocol.
Under extreme and austere circumstances, the risk:benefit ratio of whole blood transfusion favors its use. Fresh whole blood may, at times, be advantageous even when conventional component therapy is available.
目前,大多数全血输注的适应症仅通过血液成分疗法就能得到很好的处理,但在美国军队中,使用新鲜全血复苏战斗伤员的做法仍在继续。
将已发表的关于军事和民用环境中全血使用的描述与2004 - 2005年驻扎在巴格达的第31战斗支援医院(31st CSH)的全血使用情况进行比较。
对全血与成分疗法的后勤、安全性和相对疗效的担忧使得在大多数情况下反对使用全血。然而,军事医生观察到,在对酸中毒、体温过低和凝血功能障碍的创伤患者进行大规模复苏时,新鲜温热全血相对于成分疗法具有一些明显的优势。在这一关键作用中,新鲜全血最终被纳入一种新型的基于全血的大规模输血方案中作为辅助手段。
在极端和严峻的情况下,全血输注的风险效益比有利于其使用。即使在有传统成分疗法可用时,新鲜全血有时也可能具有优势。